Department of Hematology

血液科 · The Affiliated Hospital of Chengdu University, Chengdu

Established in 2010, this department diagnoses and treats red blood cell disorders, hematologic malignancies, coagulation diseases, and critical blood conditions. The team includes nearly 20 staff members, with five specialist physicians, managing 40 general beds and four sterile laminar flow beds. Clinical expertise covers leukemia, lymphoma, multiple myeloma, and cytopenias. The department utilizes targeted therapies such as bortezomib, rituximab, and decitabine. It offers genetic testing for mutations like JAK2 and FLT3 to guide personalized treatment. As a designated hemophilia care center in Chengdu, the unit provides multidisciplinary management for hemophilia A and B patients, supported by regular education programs.

Conditions and treatments

Key facts

Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.

SpecialtyHematology
Doctors listed6
Chief physicians1

Senior doctors

Chief and associate chief physicians listed for this department on public doctor-listing platforms (2025–2026).

Chief physicians

We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.

Need a specialist's opinion?

Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.

Contact us